UR Medicine Faculty
The University of Rochester Medical Faculty Group
(URMFG) consists of over 900 specialist and primary care providers spanning 19
departments.
URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner
Accountable Health Partners (AHP) is a network of
over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the
region. AHP offers a full range of care.
Doctor Thomas Frye currently serves as Associate Professor of Urology and Vice Chair of Clinical Affairs for the Department of Urology at the University of Rochester Medical Center. Dr. Frye, is a Urologic Oncologist who specializes in both minimally invasive urologic oncology (robotic surgery of pr...
Doctor Thomas Frye currently serves as Associate Professor of Urology and Vice Chair of Clinical Affairs for the Department of Urology at the University of Rochester Medical Center. Dr. Frye, is a Urologic Oncologist who specializes in both minimally invasive urologic oncology (robotic surgery of prostate and kidney cancers), and advanced open pelvic and retroperitoneal cancer surgery. He has a special interest and expertise in the management of localized prostate cancer with focal therapy. Dr. Frye has the most comprehensive focal therapy program in upstate New York and offers High Intensity Focused Ultrasound (HIFU), cryotherapy, as well as other ablative technologies. He also participates in national clinical trials evaluating the efficacy of focal therapy for prostate cancer.
Dr. Frye was the valedictorian of his class where he graduated with a Doctor of Osteopathy degree from Midwestern University, Chicago College of Osteopathic Medicine. He went on to complete his urology residency at Southern Illinois University School of Medicine. Dr. Frye was chosen for the prestigious fellowship training in Urologic Oncology within The National Cancer Institute at the National Institutes of Health (NIH) in Bethesda, Maryland.
Dr. Frye’s research projects focus on optimizing the screening, diagnosis and treatment of men with prostate cancer. During his fellowship, he worked extensively in refining the use of prostate MRIs in men on active surveillance. Dr. Frye's clinical research interest also includes advanced imaging for prostate cancer as well as focal therapy of prostate cancer.
Dr. Frye is involved in multiple specialty societies including the American Urological Association (AUA), Society of Urologic Oncology (SUO), American Society of Clinical Oncology, and Focal Therapy Society.
Certified Specialties
Urology
- American Board of Urology
Faculty Appointments
Associate Professor
-
Department of Urology (SMD)
Credentials
Residency & Fellowship
Fellowship, Urologic Oncology, National Cancer Institute/National Institute of Health. 2014 - 2016
Residency, Urology, Southern Illinois University School Of Medicine. 2010 - 2014
Internship, Urology, Southern Illinois University School Of Medicine. 2009 - 2010
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to othe...
Ghazi A, Melnyk R, Hung AJ, Collins J, Ertefaie A, Saba P, Gurung P, Frye T, Rashid H, Wu G, Mottrie A, Costello T, Dasgupta P, Joseph J
BJU international.. 2021 June 127 (6):645-653. Epub 10/06/2020.
Incorporation and validation of clinically relevant performance metrics of simulation (CRPMS) into a novel full-immersion simulation platform for nerve-sparing robot-assisted radical prostatectomy (NS-RARP) utilizing three-dimensional printing and hydrogel casting technology.
Witthaus MW, Farooq S, Melnyk R, Campbell T, Saba P, Mathews E, Ezzat B, Ertefaie A, Frye TP, Wu G, Rashid H, Joseph JV, Ghazi A.
BJU Int. 2020; .
Cribriform pattern and perineural invasion on MR/US fusion biopsy predict failure of selection criteria for prostatic hemigland ablation
Mithal P, Truong M, Quarrier S, Lu D, Hollenberg G, Weinberg E, Miyamoto H, Frye T.
Urol Oncol. 2020; .
Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging
Truong M, Baack Kukreja JE, Rais-Bahrami S, Barashi NS, Wang B, Nuffer Z, Park JH, Lam K, Frye TP, Nix JW, Thomas JV, Feng C, Chapin BF, Davis JW, Hollenberg G, Oto A, Eggener SE, Joseph JV, Weinberg E, Messing EM.
Eur Urol Oncol. 2019; .
Sonographic Diagnosis of Unilateral Synchronous Testicular Tumors
Forrest A, Numbere N, Jean-Gilles J, Frye T, Dogra V.
Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, Lerner S, Palapattu G, Wilding G, Droller M, Trump D
Bladder cancer.. 2018 October 34 (Suppl 1):S1-S43. Epub 10/03/2018.
A Comprehensive Analysis of Cribriform Morphology on MR/US Fusion Biopsy Correlated with Radical Prostatectomy Specimens.
Truong M, Feng C, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP.
Journal of Urology. 2018; .
Historical and contemporary perspectives on cribriform morphology in prostate cancer.
Truong M, Frye T, Messing E, Miyamoto H.
Nat Rev Urol. 2018; .
Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy.
Truong M;Frye TP.
Transl Androl Urol. 2017; 6(3): 424-431.
MRI-TRUS Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer
Frye TP, George A, Kilchevsky A, Maruf M, Siddiqui M, Kongnyuy M, Muthigi A, Han H, Parnes H, Merino M, Choyke P, Turkbey B, Wood B, Pinto P.
Journal of Urology. 2017; .
Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric MRI: Correlation with Final Histopathology
Truong M, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP.
Journal of Urology. 2017; .
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy
Maruf M, Fascelli M, George AK, Siddiqui MM, Kongnyuy M, DiBianco JM, Muthigi A, Valayil S, Sidana A, Frye TP, Kilchevsky A, Choyke PL, Turkbey B, Wood BJ, Pinto PA.
Prostate Cancer Prostatic Dis. 2017; .
Prostate Cancer Diagnosis on repeat MRI-TRUS Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling
Chelluri R, Kilchevsky A, George AK, Sidana A, Frye TP, Su D, Fascelli M, Ho R, Abboud SF, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Reproducibility of Multiparametric MRI and Fusion-Guided Prostate Biopsy: Multi-Institutional External Validation by a Propensity Score Matched Cohort
Rastinehad AR, Abboud SF, George AK, Frye T, Ho R, Chelluri R, Fascelli M, Shih J, Villani R, Ben-Levi E, Yaskiv O, Turkbey B, Choyke PL, Merino MJ, Wood BJ, Pinto PA.
J Urol. 2016; pii: S0022-5347(16)00129-4.
Reproducibility of Multiparametric Magnetic Resonance Imaging and Fusion Guided Prostate Biopsy: Multi-Institutional External Validation by a Propensity Score Matched Cohort.
Rastinehad AR, Abboud SF, George AK, Frye T, Ho R, Chelluri R, Fascelli M, Shih J, Villani R, Ben-Levi E, Yaskiv O, Turkbey B, Choyke PL, Merino MJ, Wood BJ, Pinto PA.
Journal of Urology. 2016; .
The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men
Kongnyuy M, Sidana A, George AK, Muthigi A, Iyer A, Fascelli M, Kadakia M, Frye TP, Ho R, Mertan F, Minhaj Siddiqui M, Su D, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA.
Urol Oncol. 2016; .
Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification.
18. Muthigi A, Sidana A, George AK, Kongnyuy M, Shakir N, Kadakia M, Maruf M, Frye TP, Mertan F, Su D, Merino MJ, Choyke PL, Turkbey B, Wood BJ, Pinto PA.
Int Urol Nephrol. 2016; .
Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy
Ho R, Siddiqui MM, George AK, Frye T, Kilchevsky A, Fascelli M, Shakir NA, Chelluri R, Abboud SF, Walton-Diaz A, Sankineni S, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA.
PLoS One. 2016; .
Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification
Muthigi A, Sidana A, George AK, Kongnyuy M, Shakir N, Kadakia M, Maruf M, Frye TP, Mertan F, Su D, Merino MJ, Choyke PL, Turkbey B, Wood BJ, Pinto PA.
Int Urol Nephrol. 2016; .
Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers
Watson MJ, George AK, Maruf M, Frye TP, Muthigi A, Kongnyuy M, Valayil SG, Pinto PA.
Future Oncol. 2016; .
Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis
Kongnyuy M, Sidana A, George AK, Muthigi A, Iyer A, Ho R, Chelluri R, Mertan F, Frye TP, Su D, Merino MJ, Choyke PL, Wood BJ, Pinto PA, Turkbey B.
Urol Oncol. 2016; .
A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis
Kongnyuy M, Frye TP, George AK, et al.
Case Reports in Urology. 2015; .
Combined Biparametric Prostate MRI and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy Naïve Patient Population
Fascelli M, Rais-Bahrami S, Sankineni S, Brown AM, George AK, Ho R, Frye T, Kilchevsky A, Chelluri R, Abboud S, Siddiqui MM, Merino MJ, Wood BJ, Choyke PL, Pinto PA, Turkbey B.
Urology. 2015; pii: S0090-4295(15)01091-2.
Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection
Frye TP, Pinto PA, George AK.
Curr Urol Rep. 2015; 16(7):50.
The role of MRI in active surveillance for prostate cancer
Fascelli M, George AK, Frye T, Turkbey B, Choyke PL, Pinto PA.
Curr Urol Rep. 2015; 16(6):42.
Impact of County Rurality and Urologist Density on Urologic Cancer Mortality in Illinois
Conservative management and female gender are associated with increased cancer?specific death in patients with isolated primary urothelial carcinoma in situ.
Robot-Assisted Inguinal Lymphadenectomy for Urethral Carcinoma
Frye TP, Gorbonos A.
J Laparoendoscopic & Advanced Surgical Techniques and Part B: Videoscopy. 2014; .
Ocular Radiation Exposure in Modern Urologic Practice
Taylor ER, Kramer B, Frye TP, Wang S, Schwartz BF, Köhler TSJ.
Urol. 2013; .
Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell response
Johnson LE, Frye TP, McNeel DG.
OncoImmunology. 2012; 1;1(9):1546-1556.
Patient Satisfaction of Vacuum Erection Device (VED) Use After Prostate Cancer Treatment: Three and Six Month Outcomes from a VED Registry
Kohler TS, Frye TP, Rewcastle JC, Mulhall JP.
J Sex. Med. 2012; 9:219.
HLA-A2 restricted T-cell epitopes specific for prostatic acid phosphatase
Olson BM, Frye TP, Johnson LE, Fong L, Knutson KL, Disis ML, McNeel DG . 2010 Jun;.
Cancer Immunol Immunother. 2010; 59(6):943-53.
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer
McNeel DG, Dunphy EJ, Davies JG, Frye TP, Johnson LE, Staab MJ, Horvath DL, Straus J, Alberti D, Marnocha R, Liu G, Eickhoff JC, Wilding G.
J Clin Oncol. 2009; 27:4047-4054.
Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T-cells
Johnson LE, Frye TP, Chinnasamy N, Chinnasamy G, and McNeel DG.
Cancer Immunol Immunother. 2007; 56(6):885-95.
Safety and immunological efficacy of prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP)
Johnson LE, Frye TP, Arnot AR, Marquette C, Couture LA, Gendron-Fitzpatrick A, and McNeel DGVaccine.
2006; 24:293-303.
New approaches to identification of antigenic candidates for future prostate cancer immunotherapy
Dunphy EJ, Johnson LE, Olson BM, Frye TP, McNeel DG.
Update on Cancer Therapeutics. 2006; 22:273-284.
Books
Neuropsychology of Cancer and Oncology
(2012)
Chapter: Neuropsychology of Genitourinary Malignancies
Authors: Frye TP, Miller J, Tarter TH
Publisher:
Springer Publishing Company 2012
Ratings & Comments
At URMC, we believe that patients should be empowered to make the right decisions regarding their
personal
healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all
aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying
star ratings for our providers along with anonymous patient comments on our website. This will help you make
better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used
to generate this vital information. Learn more about
our survey process.
Ratings
Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)
4.9 stars
Likelihood of recommending this care provider to others
4.9 stars
Explanations the care provider gave you about your problem or condition
4.9 stars
Care provider's efforts to include you in decisions about your care
4.9 stars
Concern the care provider showed for your questions or worries
4.9 stars
Patient Comments
5.0 stars
Gave friend a referral to see Dr Frye.
Dec 16, 2024
5.0 stars
Dr. Frye is incredibly knowledgeable, caring and clearly an expert in his field. He helped me through a very challenging time to successfully address my issues.
Dec 09, 2024
5.0 stars
Dr. Frye is a credit to UR Medicine. I traveled 100 miles because of his reputation, and was not disappointed.
Dec 08, 2024
5.0 stars
The. Entire visit. Very. Good
Dec 07, 2024
5.0 stars
Dr. Thomas Frye was thorough, kind knowledgeable and extremely helpful during this consultation and in planning a path forward to address my concerns.
Nov 24, 2024
5.0 stars
Dr. Frye exhibits such confidence and knowledge of his field that I am left feeling very lucky that I found him and was under his care.I guess I am now a Cancer survivor but I almost feel like I cheated from how easy Dr Frye made this whole ordeal.
Nov 11, 2024
5.0 stars
Dr. Frye and staff are a credit to the medical profession.
Oct 27, 2024
5.0 stars
He was great
Oct 26, 2024
5.0 stars
Dr Frye was prompt, explained my test results clearly and showed comparisons to previous tests, very thorough. I feel I am getting the best possible care.
Oct 25, 2024
2.2 stars
Dr. Frye did not have any "bed side manner". [...] I did not come away feeling like he cared about me or any treatment possibilities.
Oct 12, 2024
5.0
I am a post-treatment monitoring patient, with no current symptoms or problems. Relatively limited experience and contact, very pleased with Dr Frye so far. I'll feel no hesitation to call with issues or questions If and when they emerge.
Oct 08, 2024
5.0
I have recommended in the past
Sep 29, 2024
5.0
Dr. Frye was incredible at listening to my concerns and at advising a plan to address my concerns. He was clearly very experienced in all matters. I give him an A+
Sep 17, 2024
5.0
Have already made recommendations to others
Sep 16, 2024
5.0
Good
Aug 25, 2024
5.0
Informed me of my options and status.
Aug 12, 2024
5.0
Dr Frye is very good at listening. He is an excellent urologist.
Jul 28, 2024
5.0
Per my prior comments both Dr. Frye and PA Amanda Buckner were excellent with care provided, interpreting data and test results and communicating a plan. Thank you.
Jul 06, 2024
5.0
Excellent
Jun 30, 2024
5.0
I have recommended 2 people who have since hd appointments with Dr. Frye
Jun 11, 2024
5.0
Dr and staff had my interests in mind!
Jun 10, 2024
5.0
I have recommended him
Jun 01, 2024
5.0
Felt vert good with results
May 12, 2024
5.0
Dr. Frye is very knowledgable and competent as a health practitioner. He was very thorough when going over my recent test results - PSA and Urinalysis. He has a very fine caring manner and is really personable. I have a high degree of confidence in him.
Mar 12, 2024
5.0
The entire team that works with Dr Frye are all very good and always listen to what I have to say.
Jan 06, 2024
5.0
Excellent physician!!
Dec 14, 2023
5.0
Dr Frye and his staff are terrific
Nov 11, 2023
Excellent Doctor and Nurse experience. Answered all my questions and showed compassion and concern for my issues. I would recommend U of R Urological services and doctors to everyone
Oct 30, 2023
5.0
Doctor Frye showed great empathy, and provided options for care, along with understandable reasons for those options.
Oct 21, 2023
5.0
This Dr did my surgery and I would recommend him to others.
Sep 28, 2023
5.0
No complaints
Sep 24, 2023
5.0
A thorough explanation of treatment options was given
Aug 05, 2023
5.0
Based on my initial encounter, Dr. Frye is a first rate practitioner.
Jul 29, 2023
5.0
Everything was very good
Jul 14, 2023
5.0
I have recommended Dr Frye many times
Jun 25, 2023
3.0
We felt that Dr. Frye was in a hurry gave us the feeling of why we were there. [...]
Jun 12, 2023
5.0
Both the doctor and PA explained a prospective procedure to me, and did not pressure me to undergo it until I felt I needed it.
May 31, 2023
5.0
He is a good doctor who seems to care about his patients. I am glad to have him as a surgeon
May 29, 2023
5.0
The Dr. Was Excellent.
May 05, 2023
5.0
Good
Apr 23, 2023
5.0
Dr. Frye listened, expalined all questions to my complete satisfaction
Mar 22, 2023
5.0
The Dr is very good. He listens to my problems and address them. He is excellent
Feb 13, 2023
5.0
Dr Frye and his team have been great.
Feb 09, 2023
Dr. Frye was very generous with his time and very responsive to my questions. His presentation about treatment options was very cogent and candid.
Feb 03, 2023
5.0
Both the PA and doctor were very good.The PA explained things from my lab test and answered my questions.
Jan 26, 2023
5.0
Dr. Frye is an excellent doctor. He is professional, friendly and helpful. He is a definite asset to URMC.
Jan 16, 2023
5.0
I have the highest regard for Dr. Frye. He has guided me through the process of treating my prostate cancer, from beginning to end, with the utmost degree of professionalism and sense of care. I cannot thank him enough, and am grateful to have had him as my urologist.
Dec 20, 2022
5.0
Dr. Frye was excellent.
Dec 17, 2022
5.0
Dr. Frye was attentive to detail on my biopsy results and addressed my concern of possible prostate cancer. He ordered a PSA bloodtest.
Nov 16, 2022
5.0
This Dr is very good. He listened to my problems and provided a direction to go
Oct 30, 2022
5.0
More tests were needed and he wanted to consult w/colleagues - He quickly followed up when both those pieces were available.
Oct 19, 2022
5.0
My experience with Dr. Frye was excellent
Oct 15, 2022
3.8
Good Experience
Sep 22, 2022
5.0
The Dr reviewed the surgery and biopsy and told me what is to be done in the future. He exudes confidence and I was pleased to have him as my surgeon
Sep 18, 2022
5.0
Dr Frye was pretty cut & dry about my situation, but I appreciate that - I asked about different tests but he responded with practical experience from similar cases and I agreed that it seemed like the right way to go
Sep 07, 2022
5.0
I trust Dr. Frye and his team with my life!
Sep 05, 2022
I admire his confidence
Aug 27, 2022
5.0
AGAIN, I KNOW YOU ARE PRETTY BUSY, AND I AM ENCOURAGED NOW, BUT IT TOOK A LONG TIME TO GET TO THIS POINT IN MY CARE. I WAS REALLY WORRIED, NOW I FEEL I HAVE A GOOD CHANCE TO GET BETTER!
Aug 24, 2022
5.0
Dr. Frye answered all my questions; gave me a lot of good information, put me at ease; explained everything he told me. He's caring, kind, very patient, and I'm very happy & confident with him as my doctor.
Aug 15, 2022
5.0
Provider was Good .
Aug 03, 2022
5.0
Good very informative
Jul 23, 2022
5.0
I don't think my experience could be better Dr Frye used techniques for minimal pain and quick recovery
Jul 10, 2022
1.4
Dr. Frye may be excellent at surgery but he needs to work on his interpersonal skills. He asked me my symptoms then interrupted me when I started talking about them to tell me nothing is wrong. He didn't explain his impression well, didn't ask if I had questions. Even if he's correct in his assessment, if a patient doesn't feel heard the patient will be unsatisfied with the impression. [...] I'm not sure how much my opinion matters in the long run. I'm just one patient, he apparently does well enough at his job that my job seems like a hobby and the rest of the world doesn't matter. I'll keep the rest of my impression to myself.
